Body-focused mindfulness added to inpatient alcohol use disorder treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study adds a body-focused mindfulness program to standard inpatient AUD treatment to see if it improves interoceptive awareness and reduces bodily dissociation. It compares six weekly 90-minute mindfulness sessions plus home practice to standard psychoeducation within the same inpatient setting. Key outcomes include changes in bodily dissociation, interoceptive awareness, and cravings, as well as relapse risk after hospital discharge. Sessions include breath work, body scan, gentle movement, and group reflection, delivered by trained therapists. Audio-guided practices support daily at-home practice.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of Alcohol Use Disorder (DSM-5)
* Currently admitted to the inpatient AUD treatment program at the study ward
* Age 18 years or older
* Written informed consent provided

Exclusion Criteria:

* Refusal to participate or withdrawal of consent
* Severe somatic condition precluding participation in group activities
* Current acute psychotic symptoms
* Severe affective symptoms requiring intensive intervention
* High current suicide risk
* Epileptic seizure within 2 weeks prior to randomization
* Intellectual disability or significant cognitive impairment preventing understanding of or adherence to the study protocol
* Severe personality disorder with current self-harm or other-harm behaviors

Where it's running

• Ward XVIII for Alcohol Use Disorder Treatment, Nowowiejski Hospital, Warsaw
  Warsaw, Mazovian, Poland Recruiting

Study contacts

• Principal investigator: Andrzej Jakubczyk, MD, PhD — Medical University of Warsaw
• Study coordinator: Andrzej Jakubczyk, MD, PhD
• Email: andrzej.jakubczyk@wum.edu.pl
• Phone: +48506647114

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Psychedelic DMT for Alcohol Use Disorder

  This trial will test whether a single psychedelic dose of DMT plus a short course of psychotherapy helps people with Alcohol Use Disorder drink less.

  Recruiting Phase 1 Yale University · New Haven, Connecticut · NCT06070649

• Imaging Mitochondrial Complex-I and Brain Metabolism in Alcohol Use Disorder

  This study tests whether PET imaging with [18F]BCPP-EF and [18F]FDG can reveal differences in brain energy use between adults with alcohol use disorder and healthy controls, and whether these measures relate to relapse risk.

  Recruiting Early Phase 1 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07825818

• Endurance exercise to see if it lowers alcohol use in adults with AUD and ALD

  A 12-week home-based cycling program added to standard care is tested to see if it reduces alcohol use and cravings in adults with alcohol use disorder and alcohol-related liver disease.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07824089

• Do beverage cues drive craving in adults with AUD

  In adults with alcohol use disorder, this study tests whether different non-alcoholic beverage cues can trigger cravings differently when people see and smell them without drinking.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT07788716

• Semaglutide for Alcohol Use Disorder and Obesity: Testing 1.0 mg and 2.0 mg vs Placebo

  We’re testing two doses of semaglutide to see if they reduce alcohol craving and use in adults with alcohol use disorder and obesity compared with placebo.

  Recruiting at 2 sites Phase 1 Yale University · New Haven, Connecticut and 1 other locations · NCT07772960

• TRIS: a mobile app with breathalyzer to support sobriety in alcohol use disorder

  A smartphone app with a connected breathalyzer tests for abstinence and uses small financial incentives to encourage sobriety for adults with AUD in Brazil.

  Recruiting University of Sao Paulo General Hospital · São Paulo, São Paulo · NCT07735585

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.